<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-76150</identifier>
<setSpec>0210-5020</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Pharmaceutical characteristics of oral anti-diabetes medicines</dc:title>
<dc:description xml:lang="en">An update regarding the principles of hyperglycemia pharmaceuticals used in daily practice, analyzing their form of administration, their adverse effects, counter indications, and interactions(AU)</dc:description>
<dc:creator>Leyva-Moral, Juan Manuel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Actualización sobre los principales fármacos hipoglicemiantes utilizados en la práctica diaria, analizando su forma de administración, sus efectos adversos, contraindicaciones e interacciones(AU)</dc:description>
<dc:source>Rev Enferm;32(2): 86-87, feb. 2009. tab</dc:source>
<dc:identifier>ibc-76150</dc:identifier>
<dc:title xml:lang="es">Características farmacológicas de los antidiabéticos orales</dc:title>
<dc:subject>^d7182^s22078</dc:subject>
<dc:subject>^d7182^s22079</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d6858^s22066</dc:subject>
<dc:subject>^d7530^s22066</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d11757^s22074</dc:subject>
<dc:subject>^d3942^s22024</dc:subject>
<dc:subject>^d7182^s22073</dc:subject>
<dc:subject>^d11757^s22045</dc:subject>
<dc:subject>^d13247^s22049</dc:subject>
<dc:subject>^d11757^s22066</dc:subject>
<dc:type>article</dc:type>
<dc:date>200902</dc:date>
</metadata>
</record>
</ibecs-document>
